These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 38539238)

  • 1. Neuropathological changes associated with aberrant cerebrospinal fluid p-tau181 and Aβ42 in Alzheimer's disease and other neurodegenerative diseases.
    Kurihara M; Matsubara T; Morimoto S; Arakawa A; Ohse K; Kanemaru K; Iwata A; Murayama S; Saito Y
    Acta Neuropathol Commun; 2024 Mar; 12(1):48. PubMed ID: 38539238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal Fluid Biomarkers in Autopsy-Confirmed Alzheimer Disease and Frontotemporal Lobar Degeneration.
    Mattsson-Carlgren N; Grinberg LT; Boxer A; Ossenkoppele R; Jonsson M; Seeley W; Ehrenberg A; Spina S; Janelidze S; Rojas-Martinex J; Rosen H; La Joie R; Lesman-Segev O; Iaccarino L; Kollmorgen G; Ljubenkov P; Eichenlaub U; Gorno-Tempini ML; Miller B; Hansson O; Rabinovici GD
    Neurology; 2022 Mar; 98(11):e1137-e1150. PubMed ID: 35173015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences between ante mortem Alzheimer's disease biomarkers in predicting neuropathology at autopsy.
    Wang ZB; Tan L; Wang HF; Chen SD; Fu Y; Gao PY; Ma YH; Guo Y; Hou JH; Zhang DD; Yu JT;
    Alzheimers Dement; 2023 Aug; 19(8):3613-3624. PubMed ID: 36840620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathological hallmarks in the post-mortem retina of neurodegenerative diseases.
    Hart de Ruyter FJ; Evers MJAP; Morrema THJ; Dijkstra AA; den Haan J; Twisk JWR; de Boer JF; Scheltens P; Bouwman FH; Verbraak FD; Rozemuller AJ; Hoozemans JJM
    Acta Neuropathol; 2024 Aug; 148(1):24. PubMed ID: 39160362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.
    Bousiges O; Cretin B; Lavaux T; Philippi N; Jung B; Hezard S; Heitz C; Demuynck C; Gabel A; Martin-Hunyadi C; Blanc F
    J Alzheimers Dis; 2016; 51(4):1069-83. PubMed ID: 26923009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline.
    Lantero Rodriguez J; Karikari TK; Suárez-Calvet M; Troakes C; King A; Emersic A; Aarsland D; Hye A; Zetterberg H; Blennow K; Ashton NJ
    Acta Neuropathol; 2020 Sep; 140(3):267-278. PubMed ID: 32720099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associating Alzheimer's disease pathology with its cerebrospinal fluid biomarkers.
    Bridel C; Somers C; Sieben A; Rozemuller A; Niemantsverdriet E; Struyfs H; Vermeiren Y; Van Broeckhoven C; De Deyn PP; Bjerke M; Nagels G; Teunissen CE; Engelborghs S
    Brain; 2022 Nov; 145(11):4056-4064. PubMed ID: 35026840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased beta-amyloid peptide42 in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration.
    Noguchi M; Yoshita M; Matsumoto Y; Ono K; Iwasa K; Yamada M
    J Neurol Sci; 2005 Oct; 237(1-2):61-5. PubMed ID: 15992827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias.
    Baiardi S; Quadalti C; Mammana A; Dellavalle S; Zenesini C; Sambati L; Pantieri R; Polischi B; Romano L; Suffritti M; Bentivenga GM; Randi V; Stanzani-Maserati M; Capellari S; Parchi P
    Alzheimers Res Ther; 2022 Oct; 14(1):153. PubMed ID: 36221099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF P-Tau181 and Other Biomarkers in Patients With Neuronal Intranuclear Inclusion Disease.
    Kurihara M; Komatsu H; Sengoku R; Shibukawa M; Morimoto S; Matsubara T; Arakawa A; Orita M; Ishibashi K; Mitsutake A; Shibata S; Ishiura H; Adachi K; Ohse K; Hatano K; Ihara R; Higashihara M; Nishina Y; Tokumaru AM; Ishii K; Saito Y; Murayama S; Kanemaru K; Iwata A
    Neurology; 2023 Mar; 100(10):e1009-e1019. PubMed ID: 36517236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
    Soleimani-Meigooni DN; Iaccarino L; La Joie R; Baker S; Bourakova V; Boxer AL; Edwards L; Eser R; Gorno-Tempini ML; Jagust WJ; Janabi M; Kramer JH; Lesman-Segev OH; Mellinger T; Miller BL; Pham J; Rosen HJ; Spina S; Seeley WW; Strom A; Grinberg LT; Rabinovici GD
    Brain; 2020 Dec; 143(11):3477-3494. PubMed ID: 33141172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of the A/T/N profiles in PET, CSF, and plasma biomarkers with Alzheimer's disease neuropathology at autopsy.
    Wang ZB; Tan L; Gao PY; Ma YH; Fu Y; Sun Y; Yu JT;
    Alzheimers Dement; 2023 Oct; 19(10):4421-4435. PubMed ID: 37506291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SCRN1: A cerebrospinal fluid biomarker correlating with tau in Alzheimer's disease.
    Weiner S; Sauer M; Brinkmalm G; Constantinescu J; Constantinescu R; Gomes BF; Becker B; Nellgård B; Dalla K; Galasko D; Zetterberg H; Blennow K; Gobom J
    Alzheimers Dement; 2023 Oct; 19(10):4609-4618. PubMed ID: 36946611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated.
    Robinson JL; Lee EB; Xie SX; Rennert L; Suh E; Bredenberg C; Caswell C; Van Deerlin VM; Yan N; Yousef A; Hurtig HI; Siderowf A; Grossman M; McMillan CT; Miller B; Duda JE; Irwin DJ; Wolk D; Elman L; McCluskey L; Chen-Plotkin A; Weintraub D; Arnold SE; Brettschneider J; Lee VM; Trojanowski JQ
    Brain; 2018 Jul; 141(7):2181-2193. PubMed ID: 29878075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CSF p-tau181/Aβ42 Ratio Offers a Good Accuracy "In Vivo" in the Differential Diagnosis of Alzheimer's Dementia.
    Santangelo R; Dell'Edera A; Sala A; Cecchetti G; Masserini F; Caso F; Pinto P; Leocani L; Falautano M; Passerini G; Martinelli V; Comi G; Perani D; Magnani G
    Curr Alzheimer Res; 2019; 16(7):587-595. PubMed ID: 31345148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer's disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study.
    Motta C; Di Donna MG; Bonomi CG; Assogna M; Chiaravalloti A; Mercuri NB; Koch G; Martorana A
    Alzheimers Res Ther; 2023 Aug; 15(1):144. PubMed ID: 37649105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at Autopsy.
    Grothe MJ; Moscoso A; Ashton NJ; Karikari TK; Lantero-Rodriguez J; Snellman A; Zetterberg H; Blennow K; Schöll M;
    Neurology; 2021 Sep; 97(12):e1229-e1242. PubMed ID: 34266917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antemortem CSF A
    Baiardi S; Abu-Rumeileh S; Rossi M; Zenesini C; Bartoletti-Stella A; Polischi B; Capellari S; Parchi P
    Ann Clin Transl Neurol; 2019 Feb; 6(2):263-273. PubMed ID: 30847359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF Biomarkers of Alzheimer Disease in Patients With Concomitant α-Synuclein Pathology.
    Cousins KAQ; Arezoumandan S; Shellikeri S; Ohm D; Shaw LM; Grossman M; Wolk D; McMillan CT; Chen-Plotkin A; Lee E; Trojanowski JQ; Zetterberg H; Blennow K; Irwin DJ
    Neurology; 2022 Nov; 99(20):e2303-e2312. PubMed ID: 36041863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer's disease at the prodromal stage.
    Bousiges O; Bombois S; Schraen S; Wallon D; Quillard MM; Gabelle A; Lehmann S; Paquet C; Amar-Bouaziz E; Magnin E; Miguet-Alfonsi C; Delbeuck X; Lavaux T; Anthony P; Philippi N; Blanc F;
    J Neurol Neurosurg Psychiatry; 2018 May; 89(5):467-475. PubMed ID: 29321140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.